JPWO2019175101A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019175101A5 JPWO2019175101A5 JP2020548696A JP2020548696A JPWO2019175101A5 JP WO2019175101 A5 JPWO2019175101 A5 JP WO2019175101A5 JP 2020548696 A JP2020548696 A JP 2020548696A JP 2020548696 A JP2020548696 A JP 2020548696A JP WO2019175101 A5 JPWO2019175101 A5 JP WO2019175101A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment system
- transdermal treatment
- activator
- weight
- transdermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000010410 layer Substances 0.000 claims 37
- 229920001296 polysiloxane Polymers 0.000 claims 32
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 29
- 239000012190 activator Substances 0.000 claims 28
- 229920000642 polymer Polymers 0.000 claims 24
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 9
- -1 aliphatic acrylates Chemical class 0.000 claims 7
- 239000008199 coating composition Substances 0.000 claims 7
- 239000013543 active substance Substances 0.000 claims 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 229920001577 copolymer Polymers 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000008385 outer phase Substances 0.000 claims 4
- 239000012071 phase Substances 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 208000018737 Parkinson disease Diseases 0.000 claims 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 3
- 239000000178 monomer Substances 0.000 claims 3
- 229910052710 silicon Inorganic materials 0.000 claims 3
- 239000010703 silicon Substances 0.000 claims 3
- 229920005573 silicon-containing polymer Polymers 0.000 claims 3
- 229920002050 silicone resin Polymers 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010012289 Dementia Diseases 0.000 claims 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 2
- 239000000853 adhesive Substances 0.000 claims 2
- 230000001070 adhesive effect Effects 0.000 claims 2
- 239000012790 adhesive layer Substances 0.000 claims 2
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229920000058 polyacrylate Polymers 0.000 claims 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims 1
- 206010057852 Nicotine dependence Diseases 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920002367 Polyisobutene Polymers 0.000 claims 1
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 208000025569 Tobacco Use disease Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 claims 1
- 229920003147 ammonioalkyl methacrylate copolymer Polymers 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 1
- 229960001736 buprenorphine Drugs 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000006482 condensation reaction Methods 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000008393 encapsulating agent Substances 0.000 claims 1
- 239000003999 initiator Substances 0.000 claims 1
- 238000010030 laminating Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 claims 1
- 229960002715 nicotine Drugs 0.000 claims 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 238000004080 punching Methods 0.000 claims 1
- 229960004136 rivastigmine Drugs 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18161432.2 | 2018-03-13 | ||
| EP18161432 | 2018-03-13 | ||
| PCT/EP2019/056016 WO2019175101A1 (en) | 2018-03-13 | 2019-03-11 | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021515789A JP2021515789A (ja) | 2021-06-24 |
| JPWO2019175101A5 true JPWO2019175101A5 (https=) | 2022-03-22 |
| JP2021515789A5 JP2021515789A5 (https=) | 2022-03-22 |
Family
ID=61628186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020548696A Abandoned JP2021515789A (ja) | 2018-03-13 | 2019-03-11 | シリコーンアクリルハイブリッドポリマーを含む経皮治療システム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210000756A1 (https=) |
| EP (1) | EP3764996A1 (https=) |
| JP (1) | JP2021515789A (https=) |
| CN (1) | CN111867569A (https=) |
| BR (1) | BR112020018607A2 (https=) |
| CA (1) | CA3092775A1 (https=) |
| WO (1) | WO2019175101A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3079694A1 (en) | 2017-10-11 | 2019-04-18 | Dow Silicones Corporation | Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymer |
| CN111447926B (zh) | 2017-10-11 | 2024-04-30 | 罗曼治疗系统股份公司 | 用于透皮施用胍法辛的包含至少一种添加剂的透皮治疗系统 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
| US6974588B1 (en) * | 1999-12-07 | 2005-12-13 | Elan Pharma International Limited | Transdermal patch for delivering volatile liquid drugs |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| EP2024406B1 (en) | 2006-06-06 | 2012-08-01 | Dow Corning Corporation | A silicone acrylate hybrid composition |
| BRPI1014886B1 (pt) | 2009-04-24 | 2020-02-11 | Henkel IP & Holding GmbH | Polímeros acrílicos de silicone híbridos, seus métodos de preparação, adesivos e soluções de uma composição adesiva sensível à pressão compreendendo os mesmos. |
| JP2013139554A (ja) * | 2011-11-29 | 2013-07-18 | Dow Corning Corp | シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法 |
| TW201338813A (zh) | 2011-12-12 | 2013-10-01 | 洛曼治療系統股份有限公司 | 經皮遞送系統 |
| AU2013205080B2 (en) * | 2012-12-12 | 2016-07-07 | Lts Lohmann Therapie-Systeme Ag | Transdermal Delivery System |
| US10316228B2 (en) | 2015-02-09 | 2019-06-11 | Dow Silicones Corporation | Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same |
| US20170112781A1 (en) * | 2015-10-27 | 2017-04-27 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems with polyisobutylene face adhesive |
| KR102381686B1 (ko) * | 2016-07-22 | 2022-04-01 | 에르테에스 로만 테라피-시스테메 아게 | 접착제 도메인의 제어 |
-
2019
- 2019-03-11 EP EP19708861.0A patent/EP3764996A1/en not_active Withdrawn
- 2019-03-11 US US16/979,575 patent/US20210000756A1/en not_active Abandoned
- 2019-03-11 JP JP2020548696A patent/JP2021515789A/ja not_active Abandoned
- 2019-03-11 CA CA3092775A patent/CA3092775A1/en active Pending
- 2019-03-11 CN CN201980019154.6A patent/CN111867569A/zh active Pending
- 2019-03-11 WO PCT/EP2019/056016 patent/WO2019175101A1/en not_active Ceased
- 2019-03-11 BR BR112020018607-4A patent/BR112020018607A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016215180B2 (en) | Pressure-sensitive adhesives for transdermal drug delivery | |
| JPH0314809B2 (https=) | ||
| WO2014062494A1 (en) | Compositions and methods for the transdermal delivery of methylphenidate | |
| KR0163597B1 (ko) | 니트로글리세린의 경피 투여형 약제 | |
| JPH0725669B2 (ja) | 経皮投与用医薬製剤 | |
| US4971799A (en) | Percutaneous-administration-type pharmaceutical preparation of nitroglycerin | |
| WO2000019986A1 (en) | Tape material for transcutaneous absorption | |
| JP2021515789A5 (https=) | ||
| JP2021517572A5 (https=) | ||
| JP3542814B2 (ja) | 消炎鎮痛貼付剤 | |
| JPWO2019175101A5 (https=) | ||
| JPWO2019175109A5 (https=) | ||
| JP2021515791A5 (https=) | ||
| JPWO2019175106A5 (https=) | ||
| CN111867569A (zh) | 包含有机硅丙烯酸杂化聚合物的透皮治疗系统 | |
| JP3407073B2 (ja) | フィゾスチグミンの皮膚への投与のための経皮療法システム及びその製造方法 | |
| JP2021522187A5 (https=) | ||
| CN111971032A (zh) | 包含有机硅丙烯酸杂化聚合物的透皮治疗系统 | |
| CN112040936A (zh) | 用于透皮施用索利那新的透皮治疗系统 | |
| JP2021517569A5 (https=) | ||
| JP4255536B2 (ja) | 新規貼付剤 | |
| JP3676567B2 (ja) | 医療用粘着剤組成物及び医療用貼付剤 | |
| JPH06239753A (ja) | 抗血栓経皮吸収製剤 | |
| JPS5835113A (ja) | 複合製剤 | |
| JPS6320410B2 (https=) |